Ardelyx (ARDX) is emerging as a compelling, yet risky, small-cap biotech opportunity. The company has made significant ...

Dubai resident Charmy* took a genetic test hoping it would solve a medical mystery that had been plaguing her for decades.

Fit 40-year-old Tracy Robert was told her bleeding and bloating were just IBS, until her health deteriorated so far it ...